1)Robinson TE, Berridge KC:The psychology and neurobiology of addiction:An incentive-sensitization view. Addiction 95(Suppl 2):S91-117, 2000[PMID:11002906]
2)Bechara A:Decision making, impulse control and loss of willpower to resist drugs:A neurocognitive perspective. Nat Neurosci 8:1458-1463, 2005[PMID:16251988]
3)Morgenstern J, Naqvi NH, Debellis R, et al:The contributions of cognitive neuroscience and neuroimaging to understanding mechanisms of behavior change in addiction. Psychol Addict Behav 27:336-350, 2013[PMID:23586452]
4)Vuchinich RE, Simpson CA:Hyperbolic temporal discounting in social drinkers and problem drinkers. Exp Clin Psychopharmacol 6:292-305, 1998[PMID:9725113]
5)Dixon MR, Marley J, Jacobs EA:Delay discounting by pathological gamblers. J Appl Behav Anal 36:449-458, 2003[PMID:14768665]
6)Grant JE, Potenza MN, Weinstein A, et al:Introduction to behavioral addictions. Am J Drug Alcohol Abuse 36:233-241, 2010[PMID:20560821]
7)Yau YH, Potenza MN:Gambling disorder and other behavioral addictions:Recognition and treatment. Harv Rev Psychiatry 23:134-146, 2015[PMID:25747926]
8)Blaszczynski A, Nower L:A pathways model of problem and pathological gambling. Addiction 97:487-499, 2002[PMID:12033650]
9)Dubey MJ, Ghosh R, Chatterjee S, et al: COVID-19 and addiction. Diabetes Metab Syndr 14:817-823, 2020[PMID:32540735]
10)Takahashi H, Fujie S, Camerer C, et al:Norepinephrine in the brain is associated with aversion to financial loss. Mol Psychiatry 18:3-4, 2013[PMID:22349782]
11)Franklin G, Carson AJ, Welch KA:Cognitive behavioural therapy for depression:Systematic review of imaging studies. Acta Neuropsychiatr 28:61-74, 2016[PMID:26122039]